CDK5RAP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CDK5RAP monoclonal antibodies for investigating cyclin-dependent kinase 5 regulatory subunit-associated protein. CDK5RAP monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CDK5RAP is essential for regulating cyclin-dependent kinase 5 (CDK5), which plays a significant role in neuronal development and function. Research has shown that CDK5RAP influences various cellular processes and signaling pathways critical for normal brain function. Dysregulation of CDK5 and CDK5RAP has been linked to neurodegenerative diseases and various neurological disorders. Understanding CDK5RAP function is vital for elucidating the mechanisms underlying these conditions and developing potential therapeutic strategies. Researchers can utilize CDK5RAP monoclonal antibodies to explore protein expression patterns, cellular localization, and molecular interactions. Investigating CDK5RAP can provide valuable insights into neuronal development, synaptic plasticity, and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of neurological disorders and contribute to therapeutic development.